MoneyWorks4Me

Ngl Fine-Chem informs about disclosure

18 Jun 2024 Evaluate
Ngl Fine-Chem has informed that the Company has received Certificate of suitability No. CEP 2022-025 - Rev 00, from European Directorate for the Quality of Medicines & Healthcare (EDQM) for its product Triclabendazole. This certificates facilitates registration and use of Triclabendazole manufactured by NGL Fine-Chem by the European customers for their finished product.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..